Summary
CME Group Inc. (CME) has filed an 8-K report detailing the completion of a public offering of $750 million in aggregate principal amount of 5.75% Notes due 2014. This offering, finalized on February 9, 2009, was conducted under an existing shelf registration statement. The net proceeds are earmarked for repaying outstanding commercial paper backed by the company's 364-day revolving bridge facility, with any remaining funds allocated to general corporate purposes. Additionally, the report indicates CME Group's intention to terminate its 364-day revolving bridge facility, effective February 10, 2009. This strategic move suggests a shift in the company's financing strategy, potentially driven by the successful debt issuance and its implications for liquidity management in the prevailing economic climate.
Key Highlights
- 1Completion of a $750 million public offering of 5.75% Notes due 2014.
- 2Net proceeds intended to repay outstanding commercial paper borrowings.
- 3Remaining proceeds to be used for general corporate purposes.
- 4Entry into an Underwriting Agreement with Banc of America Securities LLC, UBS Securities LLC, Barclays Capital Inc., and Lloyds TSB Bank plc.
- 5Issuance of Notes under an Indenture, as supplemented by a Fourth Supplemental Indenture.
- 6Company to terminate its 364-day revolving bridge facility effective February 10, 2009.